Review The SDS Document
DOWNLOADProduct Details
Formula
C21H16ClF3N4O3
MW
464.83
Purity
>97%
Solubility (DMSO Mg/MI)
45
Bio Chemical Notes
Marketed for the treatment of liver & kidney cancer, Sorafenib is an inhibitor of several Tyrosine protein kinases (VEGRF & PDGRF) and Raf kinases (C-Raf & B-Raf).